Equibles does not estimate personal net worth.
Get an email with a short summary when Becton Dickinson & Co publishes a filing, an earnings call transcript or a press release.
Get BDX alertsChris Reidy is recorded as CFO at Becton Dickinson & Co (BDX). Chris Reidy has spoken on 3 earnings calls across 1 company, most recently for Becton Dickinson & Co on August 5, 2021. Becton Dickinson & Co is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Becton Dickinson & Co includes David F. Melcher (Chairman), Thomas E. Polen (Chairman and Board Member), Patrick K. Kaltenbach (CTO) and 7 others.
“I'm also very pleased with our overall performance in the quarter, particularly with the base business, which showed continued strong momentum. Third-quarter revenues of $4.9 billion increased 26.9% on a reported basis and 22% on a currency-neutral basis, and we're ahead of our expectations.”
“And before I turn to the results, let me also share my enthusiasm for the spin-off of our Diabetes Care business. I see the transaction is a win-win for all stakeholders, our shareholders, our employees, our customers and our patients.”
“I’d like to begin my comments by addressing BD’s response to the COVID-19 pandemic. First, as the coronavirus emerged, I was very proud to see the response and collaboration across our team and the immediate focus on ensuring the safety and wellbeing of our BD associates around the world.”
Medical Instruments & Supplies · Healthcare
CFO
